GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,401.20p
   
  • Change Today:
    -36.60p
  • 52 Week High: 2,263.00p
  • 52 Week Low: 1,296.00p
  • Currency: UK Pounds
  • Shares Issued: 4,094.93m
  • Volume: 10,229,838
  • Market Cap: £57,378m
  • RiskGrade: 129

Other News

FTSE 100 preview: Greek delay hits shares 20-Jun-2011 This Is Money
GlaxoSmithKline gets green light over Potiga 14-Jun-2011 This Is Money

Irish zinc explorer Connemara Mining ...

11-Jun-2011 Proactive Investors
FTSE preview: Gloom over commodities 10-Jun-2011 This Is Money
FTSE preview: Shares hit by US jobs woe 06-Jun-2011 This Is Money
FTSE in-depth: Unilever up on £38bn bi... 01-Jun-2011 This Is Money
Newspaper and magazine share tips 24-May-2011 This Is Money
Midas: At last, Dogs are setting the pace 14-May-2011 This Is Money
How to enjoy the dividend revival 14-May-2011 This Is Money
Can you invest with a clear conscience? 10-May-2011 This Is Money
FTSE close: RBS, Capita up; miners rally 10-May-2011 This Is Money
FTSE 100 preview: US nerves knock shares 06-May-2011 This Is Money
FTSE preview: Shares to fall on profit-taking 04-May-2011 This Is Money
GlaxoSmithKline hit by cuts to spending 28-Apr-2011 This Is Money
FTSE preview: Shares wait on GDP & BP 27-Apr-2011 This Is Money
FTSE preview: Sluggish start after holiday 26-Apr-2011 This Is Money
City diary: Week ahead in the markets 21-Apr-2011 This Is Money
AstraZeneca to sell £1.3bn dental unit 17-Apr-2011 This Is Money
FTSE close: Next, Reckitt up; banks fall 15-Apr-2011 This Is Money
FTSE close: Banks, BP bounce; M&S, Dixon... 01-Apr-2011 This Is Money

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,401.20p
Change Today -36.60p
% Change -2.55 %
52 Week High 2,263.00p
52 Week Low 1,296.00p
Volume 10,229,838
Shares Issued 4,094.93m
Market Cap £57,378m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
65.56% below the market average65.56% below the market average65.56% below the market average65.56% below the market average65.56% below the market average
43.33% above the sector average43.33% above the sector average43.33% above the sector average43.33% above the sector average43.33% above the sector average
Price Trend
5.18% below the market average5.18% below the market average5.18% below the market average5.18% below the market average5.18% below the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Income
45.24% above the market average45.24% above the market average45.24% above the market average45.24% above the market average45.24% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
51.07% below the market average51.07% below the market average51.07% below the market average51.07% below the market average51.07% below the market average
52.38% below the sector average52.38% below the sector average52.38% below the sector average52.38% below the sector average52.38% below the sector average

What The Brokers Say

Strong Buy 3
Buy 6
Neutral 13
Sell 1
Strong Sell 2
Total 25
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q4 Q3
Ex-Div 23-Feb-23 17-Nov-22
Paid 13-Apr-23 12-Jan-23
Amount 13.75p 13.75p

Trades for 24-Mar-2023

Time Volume / Share Price
17:58 726 @ 1,392.68p
17:58 291 @ 1,392.61p
17:58 147 @ 1,392.60p
17:58 348 @ 1,390.62p
17:58 142 @ 1,390.61p

GSK Key Personnel

CEO Emma Walmsley
CFO Iain Mackay

Top of Page